AstraZeneca to present scientific advancements from growing respiratory portfolio at the American Thoracic Society conference 2017

Click here to view online. Add this email to your safelist.

18 May 2017

AstraZeneca and its global biologics research and development arm, MedImmune, will present new data from its growing respiratory portfolio and pipeline at the 113th annual conference of the American Thoracic Society (ATS) in Washington, DC, USA, 19-24 May 2017.

RSS Feed

Legal notice and Terms of Use

Cookie policy

Site map

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.